# Alnylam Pharmaceuticals, Inc.: filings

ALNY · Nasdaq · CIK 1178670 · [Healthcare](/sectors/healthcare.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/alny.md) · [Financials](/companies/alny/financials.md) · [Filings](/companies/alny/filings.md) · [Insiders](/companies/alny/insiders.md)

## Reports and events: 310 filings

Newest first, by EDGAR acceptance time (Eastern). Filter with ?form= one of: `periodic`, `8-K`, `10-K`, `10-Q`, `4`, `proxy`, `13dg`, `all`, or any form this company filed (4 722, 8-K 218, SC 13G/A 84, 10-Q 54, 144 48, CT ORDER 36, 3 31, 10-K 18, DEF 14A 18, UPLOAD 18, SC 13G 15, CORRESP 13, 424B5 12, S-8 11, ARS 10, DEFA14A 10, SCHEDULE 13G/A 6, 4/A 4, S-8 POS 4, S-3ASR 3, SCHEDULE 13G 3, 10-Q/A 2, PRE 14A 2, SEC STAFF LETTER 2, 15-12B 1, 25 1, 3/A 1, 5 1, 8-A12B 1, EFFECT 1, FWP 1, PRER14A 1, S-3 1).

| Filed | Accepted | Form | What it is | Accession |
| --- | --- | --- | --- | --- |
| 2026-10-29 | 08:20 ET | [10-Q](/filings/0001178670-26-000076.md) | Quarterly report, period 2026-09-30 | 0001178670-26-000076 |
| 2026-10-29 | 08:16 ET | [8-K](/filings/0001178670-26-000074.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001178670-26-000074 |
| 2026-07-30 | 08:11 ET | [10-Q](/filings/0001178670-26-000062.md) | Quarterly report, period 2026-06-30 | 0001178670-26-000062 |
| 2026-07-30 | 08:06 ET | [8-K](/filings/0001178670-26-000060.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001178670-26-000060 |
| 2026-05-27 | 16:30 ET | [8-K](/filings/0001628280-26-038499.md) | 5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results | 0001628280-26-038499 |
| 2026-04-30 | 08:16 ET | [10-Q](/filings/0001628280-26-028605.md) | Quarterly report, period 2026-03-31 | 0001628280-26-028605 |
| 2026-04-30 | 08:04 ET | [8-K](/filings/0001628280-26-028601.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001628280-26-028601 |
| 2026-04-06 | 16:30 ET | [DEF 14A](/filings/0001628280-26-023923.md) | Proxy statement, period 2026-05-20 | 0001628280-26-023923 |
| 2026-03-04 | 17:17 ET | [8-K](/filings/0001628280-26-014728.md) | 5.02 Departure or appointment of officers or directors | 0001628280-26-014728 |
| 2026-02-12 | 08:12 ET | [10-K](/filings/0001628280-26-007497.md) | Annual report, period 2025-12-31 | 0001628280-26-007497 |
| 2026-02-12 | 08:05 ET | [8-K](/filings/0001628280-26-007491.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001628280-26-007491 |
| 2026-01-12 | 07:30 ET | [8-K](/filings/0001628280-26-001755.md) | 2.02 Results of operations | 0001628280-26-001755 |
| 2025-12-11 | 07:25 ET | [8-K](/filings/0001193125-25-315047.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-25-315047 |
| 2025-12-03 | 16:49 ET | [8-K](/filings/0001628280-25-055084.md) | 5.02 Departure or appointment of officers or directors | 0001628280-25-055084 |
| 2025-10-30 | 08:16 ET | [10-Q](/filings/0001628280-25-047345.md) | Quarterly report, period 2025-09-30 | 0001628280-25-047345 |
| 2025-10-30 | 08:06 ET | [8-K](/filings/0001628280-25-047342.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001628280-25-047342 |
| 2025-10-03 | 16:15 ET | [8-K](/filings/0001193125-25-230201.md) | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 9.01 Financial statements and exhibits | 0001193125-25-230201 |
| 2025-09-12 | 17:17 ET | [8-K](/filings/0001193125-25-202366.md) | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 3.02 Unregistered sale of equity; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-25-202366 |
| 2025-09-10 | 07:30 ET | [8-K](/filings/0001193125-25-199686.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-25-199686 |
| 2025-07-31 | 08:11 ET | [10-Q](/filings/0001178670-25-000090.md) | Quarterly report, period 2025-06-30 | 0001178670-25-000090 |
| 2025-07-31 | 08:05 ET | [8-K](/filings/0001178670-25-000089.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001178670-25-000089 |
| 2025-06-18 | 16:48 ET | [8-K](/filings/0001178670-25-000076.md) | 5.02 Departure or appointment of officers or directors | 0001178670-25-000076 |
| 2025-05-13 | 17:01 ET | [8-K](/filings/0001178670-25-000062.md) | 5.03 Amendment to articles or bylaws; 5.07 Shareholder vote results | 0001178670-25-000062 |
| 2025-05-01 | 08:15 ET | [10-Q](/filings/0001178670-25-000052.md) | Quarterly report, period 2025-03-31 | 0001178670-25-000052 |
| 2025-05-01 | 08:09 ET | [8-K](/filings/0001178670-25-000050.md) | 9.01 Financial statements and exhibits | 0001178670-25-000050 |
| 2025-03-24 | 16:40 ET | [DEF 14A](/filings/0001178670-25-000040.md) | Proxy statement, period 2025-05-08 | 0001178670-25-000040 |
| 2025-03-21 | 18:13 ET | [8-K](/filings/0001178670-25-000038.md) | 8.01 Other events | 0001178670-25-000038 |
| 2025-03-05 | 16:33 ET | [8-K](/filings/0001178670-25-000031.md) | 5.02 Departure or appointment of officers or directors | 0001178670-25-000031 |
| 2025-02-13 | 08:31 ET | [10-K](/filings/0001178670-25-000026.md) | Annual report, period 2024-12-31 | 0001178670-25-000026 |
| 2025-02-13 | 08:09 ET | [8-K](/filings/0001178670-25-000020.md) | 9.01 Financial statements and exhibits | 0001178670-25-000020 |
| 2025-01-13 | 07:31 ET | [8-K](/filings/0001178670-25-000008.md) | 2.02 Results of operations | 0001178670-25-000008 |
| 2024-10-31 | 08:22 ET | [10-Q](/filings/0001178670-24-000053.md) | Quarterly report, period 2024-09-30 | 0001178670-24-000053 |
| 2024-10-31 | 08:10 ET | [8-K](/filings/0001178670-24-000052.md) | 9.01 Financial statements and exhibits | 0001178670-24-000052 |
| 2024-08-01 | 08:22 ET | [10-Q](/filings/0001178670-24-000041.md) | Quarterly report, period 2024-06-30 | 0001178670-24-000041 |
| 2024-08-01 | 08:11 ET | [8-K](/filings/0001178670-24-000039.md) | 9.01 Financial statements and exhibits | 0001178670-24-000039 |
| 2024-05-20 | 16:34 ET | [8-K](/filings/0001178670-24-000027.md) | 5.07 Shareholder vote results | 0001178670-24-000027 |
| 2024-05-02 | 08:21 ET | [10-Q](/filings/0001178670-24-000023.md) | Quarterly report, period 2024-03-31 | 0001178670-24-000023 |
| 2024-05-02 | 08:11 ET | [8-K](/filings/0001178670-24-000021.md) | 9.01 Financial statements and exhibits | 0001178670-24-000021 |
| 2024-04-01 | 16:31 ET | [DEF 14A](/filings/0001193125-24-083454.md) | Proxy statement, period 2024-05-16 | 0001193125-24-083454 |
| 2024-03-04 | 16:33 ET | [8-K](/filings/0001193125-24-057906.md) | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001193125-24-057906 |
| 2024-02-15 | 16:23 ET | [10-K](/filings/0001178670-24-000008.md) | Annual report, period 2023-12-31 | 0001178670-24-000008 |
| 2024-02-15 | 08:10 ET | [8-K](/filings/0001157523-24-000253.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001157523-24-000253 |
| 2024-01-19 | 16:31 ET | [8-K](/filings/0001193125-24-011278.md) | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001193125-24-011278 |
| 2024-01-08 | 07:00 ET | [8-K](/filings/0001193125-24-003854.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-24-003854 |
| 2023-11-02 | 08:22 ET | [10-Q](/filings/0001178670-23-000023.md) | Quarterly report, period 2023-09-30 | 0001178670-23-000023 |
| 2023-11-02 | 08:10 ET | [8-K](/filings/0001157523-23-001622.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001157523-23-001622 |
| 2023-10-10 | 07:30 ET | [8-K](/filings/0001193125-23-253084.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-23-253084 |
| 2023-09-28 | 17:00 ET | [8-K](/filings/0001193125-23-245768.md) | 5.02 Departure or appointment of officers or directors | 0001193125-23-245768 |
| 2023-08-03 | 08:18 ET | [10-Q](/filings/0001178670-23-000015.md) | Quarterly report, period 2023-06-30 | 0001178670-23-000015 |
| 2023-08-03 | 08:10 ET | [8-K](/filings/0001193125-23-202313.md) | 2.02 Results of operations; 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001193125-23-202313 |

Page 1 of 7. [Older](/companies/alny/filings.md?page=2)
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 31, 2026, 15:25 ET. No prices; not investment advice.